BioSpace News Archive

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic” or the “Company”), a MedTech company commercializing IzoView, an advanced breast CT (computed tomography) imaging platform for the more accurate detection and diagnosis of breast cancer, announces it has engaged a world-leading clinical research organization (CRO) ICON plc (“ICON”) to help prepare for its upcoming clinical study and submission for market authorization in the U.S.

Deka Biosciences announced that it is breaking ground on a 14,000 square foot office and lab which will house a state of the art Research and Development, Process Development, and Manufacturing facility to further develop their novel cytokine therapies.

Cartography Biosciences, launched today with $57 million in initial funding.

The latest market analysis report published by Reports and Data, titled ‘Global Foot and Ankle Devices Market – Forecast to 2028,’ thoroughly examines the Foot and Ankle Devices industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Ambulatory Surgery Center (ASC) Market – Forecast to 2028,’ thoroughly examines the Ambulatory Surgery Center (ASC) industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Preparative and Process Chromatography Market – Forecast to 2028,’ thoroughly examines the Preparative and Process Chromatography industry to provide essential data & information for the targeted readers.

CardioFocus, Inc. announced several milestones toward the development of a next generation pulse field ablation technology for treatment of AFib, including the formation of a clinical advisory board, filing of key patents and completing initial pre-clinical studies.

Agilent Technologies Inc. (NYSE: A) today announced it will release financial results for the third quarter of fiscal year 2022 after the stock market closes on Tuesday, Aug. 16.

Agiliti Inc. announced that the company will release its second quarter results after the market close on Tuesday, August 9, 2022, to be followed by a conference call at 5 p.m. Eastern Time on the same day.

Enovis Launches ARVIS ® , Only Augmented Reality Surgical Guidance System Designed Specifically to Improve Both Total Hip and Knee Replacement Surgery.